Failures of primaquine for the treatment of relapsed Plasmodium vivax malaria is a serious
challenge to malaria elimination in Ethiopia, where P. vivax accounts for up to 40% of …

Relapse of Plasmodium vivax malaria following standard primaquine dosing has been
reported from many areas, and more recently from sub-Saharan Africa. In this report we …

To define the current efficacy of Fansidar (F. Hoffmann-La Roche Ltd., Basel Switzerland)(
pyrimethamine and sulfadoxine), primaquine in a high dose, and artesunate for treating …

A retrospective analysis of all patients with Plasmodium vivax malaria who attended the
Hospital for Tropical Diseases in London, UK, between January 1994 and June 1995, was …

We studied the antirelapse efficacy of a supervised 14-d 15 mg/d regimen of primaquine
therapy (n= 131) compared with no antirelapse therapy (n= 142) in 273 patients with …

Tafenoquine was used to treat Plasmodium vivax malaria cases who had previously failed
treatment with chloroquine and primaquine. Chloroquine was followed by a loading dose of …

Gogtay et al.(1998: Transactions, 92, 341) reported use of a 5 d regimen of primaquine for
radical cure of infection by Plasmodium vivax in India. Readers should not confuse …

In an investigation of relapse patterns, 5541 cases of Plasmodium vivax malaria, from four
major industrial complexes, each received at least one, 5-day course of primaquine (at 15 …

Indonesia (MURPHY et al., 1993). In 1993 we analysed the response of 139 cases of vivax
malaria to 10 mg/kg chloroquine+ 15 m primaquine daily for 5 d (as recommended bv the a …

The efficacy of chloroquine (25 mg base/kg over 3 days) in Plasmodium vivax malaria was
evaluated in 1995/96 in 342 patients living in an endemic area on the western border of …